References

Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen

10.1001/archderm.135.5.569 · ExternalCitation · doi-reference

The autoantibody response to Ro/SSA in cutaneous lupus erythematosus

10.1001/archderm.1994.01690100046006 · ExternalCitation · doi-reference

Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus

10.1001/jamadermatol.2014.4409 · ExternalCitation · doi-reference

Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant

10.1002/1529-0131(200009)43:9<1982::aid-anr9>3.0.co;2-2 · ExternalCitation · doi-reference

Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications

10.1002/1529-0131(200107)44:7&lt;1484::aid-art269>3.0.co;2-q · ExternalCitation · doi-reference

Autoantibodies targeting Ficolin-2 in systemic lupus erythematosus patients with active nephritis

10.1002/acr.23449 · ExternalCitation · doi-reference

Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences

10.1002/art.10263 · ExternalCitation · doi-reference

Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus

10.1002/art.20156 · ExternalCitation · doi-reference

Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus

10.1002/art.20630 · ExternalCitation · doi-reference

Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential

10.1002/art.20862 · ExternalCitation · doi-reference

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

10.1002/art.23399 · ExternalCitation · doi-reference

Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease

10.1002/art.27700 · ExternalCitation · doi-reference

Association of a functional IRF7 variant with systemic lupus erythematosus

10.1002/art.30193 · ExternalCitation · doi-reference

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis

10.1002/art.38888 · ExternalCitation · doi-reference

Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus

10.1002/art.38891 · ExternalCitation · doi-reference

Anti-endothelin receptor type A autoantibodies in systemic lupus erythematosus-associated pulmonary arterial hypertension

10.1002/art.39212 · ExternalCitation · doi-reference

The 2023 ACR/EULAR antiphospholipid syndrome classification criteria

10.1002/art.42624 · ExternalCitation · doi-reference

Exploring the role of neutrophil extracellular traps in systemic lupus erythematosus: A clinical case study and comprehensive review

10.1002/art.43019 · ExternalCitation · doi-reference

Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development

10.1002/eji.200940050 · ExternalCitation · doi-reference

Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis

10.1007/s00296-010-1379-4 · ExternalCitation · doi-reference

Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus

10.1007/s00296-011-1793-2 · ExternalCitation · doi-reference

Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus

10.1007/s002960000060 · ExternalCitation · doi-reference

Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus

10.1007/s10067-008-0921-1 · ExternalCitation · doi-reference

Application of BCMA CAR-T in systemic lupus erythematosus

10.1007/s10067-026-08121-y · ExternalCitation · doi-reference

Atypical p-ANCA in PSC and AIH: a hint toward a “leaky gut”

10.1007/s12016-008-8088-8 · ExternalCitation · doi-reference

Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics

10.1007/s12079-018-0453-7 · ExternalCitation · doi-reference

Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment

10.1007/s40257-014-0098-0 · ExternalCitation · doi-reference

The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis

10.1007/s40620-021-01007-z · ExternalCitation · doi-reference

The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature

10.1016/0002-9343(80)90378-2 · ExternalCitation · doi-reference

Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study

10.1016/j.ajhg.2012.02.023 · ExternalCitation · doi-reference

Lupus hepatitis and autoimmune hepatitis (Lupoid hepatitis)

10.1016/j.amjms.2016.10.014 · ExternalCitation · doi-reference

EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update

10.1016/j.ard.2025.09.007 · ExternalCitation · doi-reference

Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren’s syndrome: An updated meta-analysis

10.1016/j.autrev.2016.12.002 · ExternalCitation · doi-reference

A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence

10.1016/j.autrev.2024.103535 · ExternalCitation · doi-reference

Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus

10.1016/j.bbrc.2004.07.051 · ExternalCitation · doi-reference

Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren’s syndrome patient

10.1016/j.bbrc.2024.150839 · ExternalCitation · doi-reference

Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme

10.1016/j.cca.2009.06.022 · ExternalCitation · doi-reference

Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity

10.1016/j.cell.2016.05.034 · ExternalCitation · doi-reference

Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus

10.1016/j.clim.2015.07.001 · ExternalCitation · doi-reference

La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease

10.1016/j.clim.2018.04.006 · ExternalCitation · doi-reference

Single-cell transcriptome reveals immunopathological cell composition of skin lesions in subacute cutaneous lupus erythematosus

10.1016/j.clim.2022.109172 · ExternalCitation · doi-reference

Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity

10.1016/j.clinbiochem.2022.12.007 · ExternalCitation · doi-reference

Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis

10.1016/j.ejmg.2021.104262 · ExternalCitation · doi-reference

Focus on molecules: galectin-3

10.1016/j.exer.2010.11.009 · ExternalCitation · doi-reference

Annexin A5 in cardiovascular disease and systemic lupus erythematosus

10.1016/j.imbio.2005.10.007 · ExternalCitation · doi-reference

Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosus

10.1016/j.intimp.2022.109197 · ExternalCitation · doi-reference

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis

10.1016/j.jaut.2015.05.009 · ExternalCitation · doi-reference

Evidence for charge-based mimicry in anti dsDNA antibody generation

10.1016/j.jaut.2022.102900 · ExternalCitation · doi-reference

Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus

10.1016/j.jneuroim.2006.09.003 · ExternalCitation · doi-reference

KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS

10.1016/j.kint.2023.09.002 · ExternalCitation · doi-reference

Autoimmune hemolytic anemia in patients with systemic lupus erythematosus

10.1016/s0002-9343(99)00413-1 · ExternalCitation · doi-reference

Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P

10.1016/s0002-9343(99)80221-6 · ExternalCitation · doi-reference

Systemic lupus erythematosus

10.1016/s0140-6736(14)60128-8 · ExternalCitation · doi-reference

Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease

10.1016/s0190-9622(96)90315-1 · ExternalCitation · doi-reference

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

10.1016/s1474-4422(08)70224-2 · ExternalCitation · doi-reference

Recent insights into the genetic basis of systemic lupus erythematosus

10.1038/gene.2009.39 · ExternalCitation · doi-reference

Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice

10.1038/ki.2011.484 · ExternalCitation · doi-reference

Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases

10.1038/labinvest.2013.106 · ExternalCitation · doi-reference

Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

10.1038/ng.79 · ExternalCitation · doi-reference

Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus

10.1038/ng.975 · ExternalCitation · doi-reference

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

10.1038/ng1782 · ExternalCitation · doi-reference

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

10.1038/nm1101-1189 · ExternalCitation · doi-reference

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

10.1038/nm1167 · ExternalCitation · doi-reference

Systemic lupus erythematosus

10.1038/nrdp.2016.39 · ExternalCitation · doi-reference

The double life of a B-1 cell: self-reactivity selects for protective effector functions

10.1038/nri2901 · ExternalCitation · doi-reference

The role of defective clearance of apoptotic cells in systemic autoimmunity

10.1038/nrrheum.2010.46 · ExternalCitation · doi-reference

Anti-DNA antibodies — quintessential biomarkers of SLE

10.1038/nrrheum.2015.151 · ExternalCitation · doi-reference

Physiology of gangliosides and the role of antiganglioside antibodies in human diseases

10.1038/s41423-020-0388-9 · ExternalCitation · doi-reference

Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery

10.1038/s41467-022-29514-y · ExternalCitation · doi-reference

Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets

10.1038/s41540-024-00482-x · ExternalCitation · doi-reference

Chimeric antigen receptor T cell therapy for autoimmune disease

10.1038/s41577-024-01035-3 · ExternalCitation · doi-reference

Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants

10.1038/s41581-023-00732-x · ExternalCitation · doi-reference

Vascular damage in systemic lupus erythematosus

10.1038/s41581-023-00797-8 · ExternalCitation · doi-reference

The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

10.1038/s41581-024-00850-0 · ExternalCitation · doi-reference

Toll-like receptor signalling in B cells during systemic lupus erythematosus

10.1038/s41584-020-00544-4 · ExternalCitation · doi-reference

Precision medicine in systemic lupus erythematosus

10.1038/s41584-023-00948-y · ExternalCitation · doi-reference

Recent advances in the diagnosis and management of neuropsychiatric lupus

10.1038/s41584-024-01163-z · ExternalCitation · doi-reference

Antigen-specific immunotherapies for autoimmune disease

10.1038/s41584-024-01201-w · ExternalCitation · doi-reference

Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies

10.1038/s41584-025-01218-9 · ExternalCitation · doi-reference

Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus

10.1038/s41584-026-01365-7 · ExternalCitation · doi-reference

TLR7 in systemic lupus erythematosus: Genetics and emerging therapies

10.1038/s41584-026-01388-0 · ExternalCitation · doi-reference

Autoimmunity and organ damage in systemic lupus erythematosus

10.1038/s41590-020-0677-6 · ExternalCitation · doi-reference

Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression

10.1038/s41590-024-01772-6 · ExternalCitation · doi-reference

Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus

10.1038/s41590-024-01846-5 · ExternalCitation · doi-reference

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

10.1038/s41591-022-02017-5 · ExternalCitation · doi-reference

Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

10.1038/s41591-025-03937-8 · ExternalCitation · doi-reference

Structural basis for antibody-mediated NMDA receptor clustering and endocytosis in autoimmune encephalitis

10.1038/s41594-024-01387-3 · ExternalCitation · doi-reference

Diagnostics of autoimmune neurodegeneration using fluorescent probing

10.1038/s41598-018-30938-0 · ExternalCitation · doi-reference

Lectin pathway components and autoantibodies as novel immunological biomarkers in systemic lupus erythematosus (SLE) patients from Western India

10.1038/s41598-025-10891-5 · ExternalCitation · doi-reference

Single-cell profiling unveils nephritis-related circulating immunological signatures in systemic lupus erythematosus patients

10.1038/s42003-025-09431-8 · ExternalCitation · doi-reference

Utilization of biomarkers in lupus nephritis

10.1053/j.ackd.2019.09.001 · ExternalCitation · doi-reference

Pulmonary complications of systemic lupus erythematosus

10.1055/s-0039-1685537 · ExternalCitation · doi-reference

In vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus

10.1056/nejmc2509522 · ExternalCitation · doi-reference

Development of autoantibodies before the clinical onset of systemic lupus erythematosus

10.1056/nejmoa021933 · ExternalCitation · doi-reference

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

10.1056/nejmoa073003 · ExternalCitation · doi-reference

Systemic lupus erythematosus

10.1056/nejmra1100359 · ExternalCitation · doi-reference

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

10.1073/pnas.0909927107 · ExternalCitation · doi-reference

Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity

10.1073/pnas.1103555108 · ExternalCitation · doi-reference

Switchable targeting of solid tumors by BsCAR T cells

10.1073/pnas.2210562119 · ExternalCitation · doi-reference

Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis

10.1073/pnas.2519445123 · ExternalCitation · doi-reference

Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: Application of the flow linear dichroism technique

10.1073/pnas.92.1.254 · ExternalCitation · doi-reference

Expression of galectin-3 modulates T-cell growth and apoptosis

10.1073/pnas.93.13.6737 · ExternalCitation · doi-reference

Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

10.1080/08916930500484849 · ExternalCitation · doi-reference

C-reactive protein (CRP) and autoimmune disease: facts and conjectures

10.1080/17402520400001751 · ExternalCitation · doi-reference

Old and new autoantibodies in systemic lupus erythematosus

10.1080/1744666x.2026.2625964 · ExternalCitation · doi-reference

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

10.1084/jem.179.4.1317 · ExternalCitation · doi-reference

Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity

10.1084/jem.181.2.453 · ExternalCitation · doi-reference

Defective B cell tolerance checkpoints in systemic lupus erythematosus

10.1084/jem.20042251 · ExternalCitation · doi-reference

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

10.1084/jem.20201138 · ExternalCitation · doi-reference

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

10.1086/428480 · ExternalCitation · doi-reference

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus

10.1093/hmg/ddm359 · ExternalCitation · doi-reference

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

10.1093/rheumatology/keae278 · ExternalCitation · doi-reference

Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis

10.1093/rheumatology/keae632 · ExternalCitation · doi-reference

Predictors of damage accrual by organ domain in systemic lupus erythematosus

10.1093/rheumatology/keaf610 · ExternalCitation · doi-reference

Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome

10.1097/00005792-199705000-00005 · ExternalCitation · doi-reference

An update on autoantibodies in systemic lupus erythematosus

10.1097/bor.0000000000000922 · ExternalCitation · doi-reference

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells

10.1101/2025.10.19.682634 · ExternalCitation · doi-reference

Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain

10.1111/1523-1747.ep12472291 · ExternalCitation · doi-reference

Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks

10.1111/cei.12296 · ExternalCitation · doi-reference

Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus

10.1111/cei.12651 · ExternalCitation · doi-reference

Autoantibodies associated with primary biliary cholangitis are common among patients with systemic lupus erythematosus even in the absence of elevated liver enzymes

10.1111/cei.13512 · ExternalCitation · doi-reference

Understanding B‐cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B‐cell immunomics approach

10.1111/imr.12660 · ExternalCitation · doi-reference

Ultraviolet radiation (UVR) induces cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: a possible mechanism for the UVR induction of cutaneous lupus lesions

10.1111/j.1365-2133.1992.tb00098.x · ExternalCitation · doi-reference

Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)

10.1111/j.1365-2249.1991.tb08155.x · ExternalCitation · doi-reference

The regulation of inflammation by galectin-3

10.1111/j.1600-065x.2009.00794.x · ExternalCitation · doi-reference

Galectins in acute and chronic inflammation

10.1111/j.1749-6632.2011.06386.x · ExternalCitation · doi-reference

Anti-phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all-comer population

10.1111/jth.15792 · ExternalCitation · doi-reference

Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases

10.1111/resp.14703 · ExternalCitation · doi-reference

DNA hydrolyzing autoantibodies

10.1126/science.1585181 · ExternalCitation · doi-reference

The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression

10.1126/science.aac7442 · ExternalCitation · doi-reference

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

10.1136/annrheumdis-2012-202460 · ExternalCitation · doi-reference

Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2

10.1136/annrheumdis-2013-204837 · ExternalCitation · doi-reference

Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification

10.1136/annrheumdis-2018-214125 · ExternalCitation · doi-reference

Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus

10.1136/annrheumdis-2020-218810 · ExternalCitation · doi-reference

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

10.1136/ard-2024-225785 · ExternalCitation · doi-reference

Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K+ CD8 T cell activation in lupus kidney

10.1136/ard-2024-225876 · ExternalCitation · doi-reference

Lupus thrombocytopenia: clinical implications and prognostic significance

10.1136/ard.2004.033100 · ExternalCitation · doi-reference

Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment

10.1136/ard.2005.041673 · ExternalCitation · doi-reference

Liver abnormalities and liver membrane autoantibodies in systemic lupus erythematosus

10.1136/ard.48.11.946 · ExternalCitation · doi-reference

Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis

10.1136/bmjresp-2023-002076 · ExternalCitation · doi-reference

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

10.1136/lupus-2015-000104 · ExternalCitation · doi-reference

Interferon pathway in SLE: One key to unlocking the mystery of the disease

10.1136/lupus-2018-000270 · ExternalCitation · doi-reference

ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies

10.1136/lupus-2021-000562 · ExternalCitation · doi-reference

Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study

10.1136/lupus-2024-001309 · ExternalCitation · doi-reference

Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value

10.1136/rmdopen-2024-005212 · ExternalCitation · doi-reference

Role of microtubule-associated proteins in the control of microtubule assembly

10.1152/physrev.1995.75.4.835 · ExternalCitation · doi-reference

The role of anti-mCRP autoantibodies in lupus nephritis

10.1159/000530928 · ExternalCitation · doi-reference

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus

10.1172/jci111251 · ExternalCitation · doi-reference

Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice

10.1172/jci114052 · ExternalCitation · doi-reference

Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells

10.1172/jci115707 · ExternalCitation · doi-reference

Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes

10.1172/jci21075 · ExternalCitation · doi-reference

Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus

10.1172/jci22820 · ExternalCitation · doi-reference

Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block

10.1172/jci27803 · ExternalCitation · doi-reference

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

10.1172/jci38010 · ExternalCitation · doi-reference

Alveolar hemorrhage in systemic lupus erythematosus: a cohort review

10.1177/0961203315605365 · ExternalCitation · doi-reference

Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis

10.1177/0961203316678674 · ExternalCitation · doi-reference

Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study

10.1177/0961203319856089 · ExternalCitation · doi-reference

Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus

10.1177/09612033241272931 · ExternalCitation · doi-reference

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus

10.1177/17562864211051497 · ExternalCitation · doi-reference

Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review

10.1177/1759720x211040696 · ExternalCitation · doi-reference

Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change

10.1182/blood-2005-05-1943 · ExternalCitation · doi-reference

Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome

10.1182/blood-2005-07-2636 · ExternalCitation · doi-reference

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

10.1182/blood-2009-04-213520 · ExternalCitation · doi-reference

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study

10.1186/ar2831 · ExternalCitation · doi-reference

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis

10.1186/ar2880 · ExternalCitation · doi-reference

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

10.1186/ar3193 · ExternalCitation · doi-reference

Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up

10.1186/s13075-015-0879-8 · ExternalCitation · doi-reference

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

10.1186/s13075-019-1878-y · ExternalCitation · doi-reference

ALW peptide ameliorates lupus nephritis in MRL/lpr mice

10.1186/s13075-019-2038-0 · ExternalCitation · doi-reference

Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis

10.1186/s13075-021-02435-9 · ExternalCitation · doi-reference

Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study

10.1186/s13075-024-03305-w · ExternalCitation · doi-reference

Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis

10.1186/s13075-025-03536-5 · ExternalCitation · doi-reference

The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus

10.1186/s42358-020-00148-2 · ExternalCitation · doi-reference

Association between the presence of autoantibodies targeting Ficolin-3 and active nephritis in patients with systemic lupus erythematosus

10.1371/journal.pone.0160879 · ExternalCitation · doi-reference

Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies

10.1378/chest.84.6.714 · ExternalCitation · doi-reference

Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI

10.1681/asn.2013090987 · ExternalCitation · doi-reference

Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): planted antigens

10.1681/asn.2014050493 · ExternalCitation · doi-reference

Cardiovascular and pulmonary manifestations of systemic lupus erythematosus

10.2174/1573397113666170704102444 · ExternalCitation · doi-reference

Systemic lupus erythematosus and antiphospholipid syndrome: Past, present, future

10.26442/00403660.2023.05.202246 · ExternalCitation · doi-reference

Clearance deficiency and cell death pathways: A model for the pathogenesis of SLE

10.3389/fimmu.2016.00035 · ExternalCitation · doi-reference

Machine learning to quantify in situ humoral selection in human lupus tubulointerstitial inflammation

10.3389/fimmu.2020.593177 · ExternalCitation · doi-reference

TRIM21/Ro52 - roles in innate immunity and autoimmune disease

10.3389/fimmu.2021.738473 · ExternalCitation · doi-reference

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis

10.3389/fimmu.2023.1181561 · ExternalCitation · doi-reference

Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

10.3389/fimmu.2024.1335998 · ExternalCitation · doi-reference

High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of B-cell epitopes for diagnostics: a case-control study

10.3389/fimmu.2024.1401156 · ExternalCitation · doi-reference

Anti-C1q antibodies: A biomarker for diagnosis and management of lupus nephritis. A narrative review

10.3389/fimmu.2024.1410032 · ExternalCitation · doi-reference

Binding of established antinuclear antibodies to neurons depends on tissue fixation and underlying autoantigens

10.3389/fimmu.2025.1674907 · ExternalCitation · doi-reference

Aberrant B cell responses as drivers of autoantibody generation and epitope diversification in SLE pathogenesis

10.3389/fimmu.2025.1731285 · ExternalCitation · doi-reference

Lupus and the lungs: The assessment and management of pulmonary manifestations of systemic lupus erythematosus

10.3389/fmed.2020.610257 · ExternalCitation · doi-reference

Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: A common trigger for different microvascular diseases

10.3389/fmed.2022.849086 · ExternalCitation · doi-reference

Clinical aspects of cutaneous lupus erythematosus

10.3389/fmed.2022.984229 · ExternalCitation · doi-reference

Pulmonary involvement in systemic lupus erythematosus: A potentially overlooked condition

10.3390/biomedicines13061485 · ExternalCitation · doi-reference

Toward precision health in autoimmunity and immune-related adverse events: The autoantibody reactome, spatial omics, and multimodal data integration

10.3390/biomedicines14051129 · ExternalCitation · doi-reference

An overview of neonatal lupus with anti-Ro characteristics

10.3390/ijms22179281 · ExternalCitation · doi-reference

Limited association between antibodies to oxidized low-density lipoprotein and vascular affection in patients with established systemic lupus erythematosus

10.3390/ijms24108987 · ExternalCitation · doi-reference

Markers of NETosis in patients with systemic lupus erythematosus and antiphospholipid syndrome

10.3390/ijms24119210 · ExternalCitation · doi-reference

Lupus nephritis biomarkers: A critical review

10.3390/ijms25020805 · ExternalCitation · doi-reference

Precise targeting of autoantigen-specific B cells in lupus nephritis with chimeric autoantibody receptor T cells

10.3390/ijms25084226 · ExternalCitation · doi-reference

Ro60-roles in RNA processing, inflammation, and rheumatic autoimmune diseases

10.3390/ijms25147705 · ExternalCitation · doi-reference

The pathogenesis, potential biomarkers and novel therapeutic strategies for tubulointerstitial nephritis in systemic lupus erythematosus-a narrative review

10.3390/ijms262210903 · ExternalCitation · doi-reference

Redefining difficult-to-treat systemic lupus erythematosus: Biomarkers of molecular refractoriness beyond clinical failure

10.3390/ijms27094026 · ExternalCitation · doi-reference

Biomarkers in Lupus Nephritis: An evidence-based comprehensive review

10.3390/life15101497 · ExternalCitation · doi-reference

Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus

10.3892/etm.2013.1051 · ExternalCitation · doi-reference

Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist

10.3899/jrheum.220089 · ExternalCitation · doi-reference

Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block

10.4049/jimmunol.0902248 · ExternalCitation · doi-reference

Type I interferon in the pathogenesis of lupus

10.4049/jimmunol.1002795 · ExternalCitation · doi-reference

Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture

10.4049/jimmunol.159.4.2033 · ExternalCitation · doi-reference

Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies

10.4049/jimmunol.168.6.3072 · ExternalCitation · doi-reference

Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells

10.4049/jimmunol.178.12.7849 · ExternalCitation · doi-reference

Autoantibodies against C1q as a diagnostic measure of lupus nephritis: Systematic review and meta-analysis

10.4172/2155-9899.1000210 · ExternalCitation · doi-reference

Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis

10.4254/wjh.v6.i6.394 · ExternalCitation · doi-reference

Systemic lupus erythematosus: history and modernity

10.47360/1995-4484-2022-397-412 · ExternalCitation · doi-reference

Clinical significance of the determination of antibodies to the NR2 subunit of glutamate N-methyl-D-aspartate receptors (aNMDAR) in patients with systemic lupus erythematosus and antiphospholipid syndrome

10.47360/1995-4484-2025-168-175 · ExternalCitation · doi-reference

The clinical significance of antibodies to ribosomal protein P (a-Rib-P) in patients with systemic lupus erythematosus and antiphospholipid syndrome

10.47360/1995-4484-2026-279-287 · ExternalCitation · doi-reference

Liver abnormalities in systemic lupus erythematosus: A prospective observational study

10.7759/cureus.15691 · ExternalCitation · doi-reference